# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-26-336646
Filing Date
2026-08-06
Accepted
2026-08-06 06:55:30
Documents
69
Period of Report
2026-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | nuvb-20260630.htm iXBRL | 10-Q | 3286777
2 | EX-10.1 | nuvb-ex10_1.htm | EX-10.1 | 1094822
3 | EX-10.4 | nuvb-ex10_4.htm | EX-10.4 | 28240
4 | EX-31.1 | nuvb-ex31_1.htm | EX-31.1 | 18143
5 | EX-31.2 | nuvb-ex31_2.htm | EX-31.2 | 18217
6 | EX-32.1 | nuvb-ex32_1.htm | EX-32.1 | 9792
7 | EX-32.2 | nuvb-ex32_2.htm | EX-32.2 | 8538
8 | GRAPHIC | img141968529_0.jpg | GRAPHIC | 22585
| Complete submission text file | 0001193125-26-336646.txt |  | 13342698

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
9 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | nuvb-20260630.xsd | EX-101.SCH | 1501871
73 | EXTRACTED XBRL INSTANCE DOCUMENT | nuvb-20260630_htm.xml | XML | 2234104

Mailing Address 1500 BROADWAY SUITE 1401 NEW YORK NY 10036
Business Address 1500 BROADWAY SUITE 1401 NEW YORK NY 10036 332-208-6102
Nuvation Bio Inc. (Filer) CIK: 0001811063 (see all company filings)

EIN.: 850862255 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39351 | Film No.: 261245820
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)